Hybridoma Development Studies and Antibody Production
HT942525R0009 · DEPT OF DEFENSE
A BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING solicitation, with responses due 2024-12-31. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
This is combined synopsis/solicitation for severable, non-personal service(s) contract to provide hybridoma development studies and antibody production for the Division of Virology at the USAMRIID, who conducts research in molecular virology, cell biology, immunology, viral virulence factor determin
Comparable recent awards in BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| JACKSON LABORATORY | $3.0M | 1 | 2026-07-01 |
| BANNER HEALTH | $30K | 1 | 2026-06-26 |
| LIFE TECHNOLOGIES CORPORATION | $51K | 1 | 2026-06-26 |
| BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE | $3.7M | n/a | 2026-06-26 |
| ILLUMINA, INC. | $56K | 1 | 2026-06-22 |
Questions
What is solicitation HT942525R0009?
Hybridoma Development Studies and Antibody Production, issued by DEPT OF DEFENSE, under NAICS 325414 (BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING). Responses are due 2024-12-31.
What do similar contracts close for?
Comparable closed awards in this category ran from $30K to $3.7M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is HT942525R0009 set aside?
Total Small Business. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.